Keyphrases
Trabecular Meshwork Cells
100%
Transforming Growth Factor-β
100%
Cross-linked Actin Networks
100%
Smad
100%
Non-Smad
100%
Extracellular Signal-regulated Kinase
40%
Nonglaucomatous
40%
Trabecular Meshwork
30%
C-Jun N-terminal Kinase
30%
ROCK Inhibitor
30%
Primary Open-angle Glaucoma
20%
MAPK Inhibitors
20%
Smad3
20%
Network Formation
20%
Kinase Inhibitor
20%
Jun N-terminal Kinase Inhibitor
20%
Actin Stress Fibers
20%
Signaling Pathway
10%
Glaucoma Patients
10%
Aqueous Humor
10%
Increased Intraocular Pressure
10%
Pathway Inhibitors
10%
Cell Strain
10%
Rho Kinase
10%
Aqueous Humor Outflow Resistance
10%
TGF-β Receptor
10%
Pathological Changes
10%
Kinase Inhibition
10%
Inhibitor Treatment
10%
4′,6-diamidino-2-phenylindole
10%
Complete Resolution
10%
Post Hoc Test
10%
Alexa
10%
Phalloidin
10%
Controlled Growth
10%
Smad3 Inhibitor
10%
NET Inhibition
10%
Medicine and Dentistry
Trabecular Meshwork
100%
Actin
100%
Prothrombin
100%
Cancer Growth Factor
100%
Mitogen-Activated Protein Kinase
40%
Receptor
30%
Phosphotransferase Inhibitor
30%
Amino Terminal Sequence
30%
Rho Kinase Inhibitor
30%
Open Angle Glaucoma
20%
Kinase
20%
Stress Fiber
20%
Analysis of Variance
10%
Signal Transduction
10%
Intraocular Pressure
10%
Aqueous Humor Outflow
10%
Aqueous Humor
10%
Phalloidin
10%
Post-Hoc Analysis
10%
Cell Strain
10%
Rho-Associated Protein Kinase
10%
Pharmacology, Toxicology and Pharmaceutical Science
Actin
100%
Prothrombin
100%
Cancer Growth Factor
100%
Mitogen Activated Protein Kinase
40%
Receptor
30%
Phosphotransferase Inhibitor
30%
Rho Kinase Inhibitor
30%
Open Angle Glaucoma
20%
Protein Kinases
10%
Phalloidin
10%